Pharmacy action fuels drug-marketing debate.
Gaylord
G
G
D000998:Antiviral Agents / Q000191:economics*; D004339:Drug Compounding; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000191:economics; D040541:Marketing; D010414:Pennsylvania; D010594:Pharmacies / Q000458:organization & administration*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000191:economics
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin